CMND Clearmind Medicine Inc. - Common Shares
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ 10-K/10-Q Jan 20, 2026
$5.87
· of 52w range
· above low
· to high
$0.7752w low
$480.0052w high
P/E
-0.0
EPS
$-30.35
your badges
52W Range
$1–$480
Analyst Rating
·
Price Target
·
P/E
-0.0
ROE
·
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
CMND Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$5.87
P/E
-0.0
EPS
$-30.35
52W Range
$1–$480
CMND Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| May 21, 2026 | 1-for-10 | Reverse |
| Dec. 15, 2025 | 1-for-40 | Reverse |
| Nov. 28, 2023 | 1-for-30 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-30.352020-10-31 → 2025-10-31
Free Cash Flow·2022-10-31 → 2022-10-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CMND | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -0.05Y avg ≈-0.0 | ≈-0.0 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | CMND | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -57.8%5Y avg ≈-172.8% | ≈-172.8% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CMND | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 1.2 | · | · | · | |
| Quick Ratio | 0.8 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $2M | $1M | $2M | $3M | $473.7K | |
| SG&A Expense | $4M | $4M | $5M | $3M | $2M | |
| Operating Income | · | · | · | $-9M | $-4M | |
| Interest Expense | $3.9K | $5.4K | · | $19.7K | · | |
| Pretax Income | $-4M | $-5M | $-9M | $-7M | $-3M | |
| Income Tax | $70.4K | $378.0K | $17.4K | $29.9K | · | |
| Net Income | $-4M | $-5M | $-9M | $-7M | $-3M | |
| EPS (Basic) | $-30.35 | $-67.80 | $-1703.04 | $-159.11 | $-88.16 | |
| EPS (Diluted) | $-30.35 | $-67.80 | $-1703.04 | $-159.11 | $-88.16 | |
| Shares (Basic) | 127,093 | 77,503 | 5,062 | 43,335 | 30,911 | |
| Shares (Diluted) | 127,093 | 77,503 | 5,062 | 43,335 | 30,911 | |
| EBITDA | · | · | · | $-9M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $7M | $5M | $128.8K | $3M | |
| Receivables | · | · | · | $69.5K | $160.9K | |
| Current Assets | $6M | $7M | $6M | $434.7K | $5M | |
| PP&E (Net) | · | · | $1.7K | $12.9K | $20.6K | |
| Intangibles | $97.4K | $108.3K | $119.3K | $130.3K | $198.0K | |
| Total Assets | $6M | $7M | $6M | $826.4K | $5M | |
| Accounts Payable | · | $526.1K | $617.0K | $1M | · | |
| Current Liabilities | $5M | $4M | $5M | · | · | |
| Total Liabilities | $5M | $4M | $5M | $2M | $357.2K | |
| Retained Earnings | $-28M | $-24M | $-19M | $-10M | $-4M | |
| Stockholders' Equity | · | $3M | $983.5K | $-1M | $4M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $-5M | $-5M | $-6M | $-4M | $-2M | |
| CapEx | · | · | · | $5.6K | $17.0K | |
| Investing Cash Flow | $-542.0K | $-238.1K | $-26.2K | $-5.6K | $-184.0K | |
| Financing Cash Flow | $3M | $6M | $12M | $511.7K | $5M | |
| Free Cash Flow | · | · | · | $-5M | · | |
| Levered FCF | · | · | · | $-5M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -57.8% | -79.6% | -254.3% | -299.4% | · | |
| ROE | · | -256.9% | -2511.1% | -937.1% | · | |
| ROIC | · | · | · | 567.7% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.7 | · | · | · | |
| Quick Ratio | 0.8 | 1.6 | · | · | · | |
| Interest Coverage | · | · | · | -433.6 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash Flow / Share | $-37.25 | $-1.57 | $-31.12 | $-3.91 | · | |
| EPS (TTM) | $-30.35 | $-67.80 | $-1703.04 | $-159.11 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-4M | $-5M | $-9M | $-7M | · | |
| P/E | -0.0 | -0.0 | -0.0 | · | · | |
| Earnings Yield | -3812.8% | -4877.7% | -46531.2% | · | · |
Per Share
| Metric | Trend | Q4 2023 |
|---|---|---|
| EPS (TTM) | $-1703.04 |
Valuation (TTM)
| Metric | Trend | Q4 2023 |
|---|---|---|
| Net Income TTM | $-9M | |
| P/E | -0.0 | |
| Earnings Yield | -46531.2% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Net Income | $-4M | $-5M | $-9M | $-7M | $-3M |
| Diluted EPS | $-30.35 | $-67.80 | $-1703.04 | $-159.11 | $-88.16 |
| Metric | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.7 | · | · | · |
| Quick Ratio | 0.8 | 1.6 | · | · | · |
| Metric | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Free Cash Flow | · | · | · | $-5M | · |
Institutional owners (13F)
Institutional activity — Q1 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 3 | 1 | 1 | 0 | · |
Compared to Q4 2025. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair. Change vs prior quarter not shown: filer coverage differs too much between these two quarters for a reliable comparison.
Company insiders 1 insider · 0 officers · 0 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10% owner | June 16, 2026 S | 81,353 | 1 | 4 | $205,924 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Jan 20, 2026